Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride for Alcohol Reduction
NCT01262287Phase 4
Key facts
- Status
- Completed
- Start
- Jan 2011
- Primary completion
- Dec 2012
- Countries
- 1
- Sponsor
- UConn Health
- Modality
- Small Molecules
- Drugs
- dutasteride
- Conditions
- alcohol dependence
01
Overview
Phase 4, randomised, double-blind trial in alcohol dependence comparing Dutasteride with Placebo (2 arms). Primary endpoint: Change Number of Standard Drinks Per Week at 8 weeks. Started Jan 2011; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Dutasteride
Dutasteride 4 mg loading dose followed by 1 mg daily
Placebo
Placebo daily
03
Endpoints
Primary
Change Number of Standard Drinks Per Week
Secondary
Change in Standard Drinks Per Week - Moderation by Genetic Variation
Beyond the preview
Go deeper on NCT01262287.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01262287.